Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation

被引:193
作者
Benoit, DSW
Anseth, KS [1 ]
机构
[1] Univ Colorado, Dept Biol & Chem Engn, Boulder, CO 80309 USA
[2] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA
关键词
heparin; poly(ethylene glycol); fibroblast growth factor; human mesenchymal stem cells; osteogenesis;
D O I
10.1016/j.actbio.2005.03.002
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Heparin was modified with methacrylate groups, copolymerized with dimethacrylated poly(ethylene glycol), and analyzed as a localized delivery vehicle for bFGF and synthetic extracellular matrix for the differentiation of hMSCs. By deriving cues from molecules normally present in the extracellular matrix (ECM), a complex network of collagens, laminin, fibronectin, glycosaminoglycans, and growth factors, synthetic cell scaffolds can be designed that actively sequester important bioactive signals. Among the glycosaminoglycans, heparin binds reversibly with many proteins, therefore,. poly(ethylene glycol) based biomaterials, normally resistant to cell adhesion, functionalized with heparin in order to sequester important proteins, can actively and selectively Stimulate desired cell functions. Results demonstrate that methacrylate-modified heparin retained its ability to bind heparin-binding proteins both in solution and when copolymerized with dimethacrylated PEG in a hydrogel. In addition, the heparin functionalized gels can deliver biologically active bFGF for up to 5 weeks. Finally,. the gels were examined as a potential scaffold for hMSC Culture and were found to promote adhesion, proliferation, and osteogenic differentiation. (c) 2005 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:461 / 470
页数:10
相关论文
共 43 条
  • [1] NUCLEOTIDE-SEQUENCE OF A BOVINE CLONE ENCODING THE ANGIOGENIC PROTEIN, BASIC FIBROBLAST GROWTH-FACTOR
    ABRAHAM, JA
    MERGIA, A
    WHANG, JL
    TUMOLO, A
    FRIEDMAN, J
    HJERRILD, KA
    GOSPODAROWICZ, D
    FIDDES, JC
    [J]. SCIENCE, 1986, 233 (4763) : 545 - 548
  • [2] Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2
    Bianchi, G
    Banfi, A
    Mastrogiacomo, M
    Notaro, R
    Luzzatto, L
    Cancedda, R
    Quarto, R
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 287 (01) : 98 - 105
  • [3] EFFECTS OF BASIC FIBROBLAST GROWTH-FACTOR ON BONE-FORMATION INVITRO
    CANALIS, E
    CENTRELLA, M
    MCCARTHY, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (05) : 1572 - 1577
  • [4] CANALIS E, 2000, SKELETAL GROWTH FACT
  • [5] BASIC FIBROBLAST GROWTH-FACTOR ENHANCES THE COUPLING OF INTIMAL HYPERPLASIA AND PROLIFERATION OF VASA VASORUM IN INJURED RAT ARTERIES
    EDELMAN, ER
    NUGENT, MA
    SMITH, LT
    KARNOVSKY, MJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) : 465 - 473
  • [6] GOSPODAROWICZ D, 1990, CLIN ORTHOP RELAT R, P231
  • [7] Polymeric biomaterials
    Griffith, LG
    [J]. ACTA MATERIALIA, 2000, 48 (01) : 263 - 277
  • [8] Gupta P, 2002, BLOOD, V100, p525A
  • [9] Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro
    Hausser, HJ
    Brenner, RE
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (05) : 1062 - 1073
  • [10] Ishihara M, 2001, J BIOMED MATER RES, V56, P536, DOI 10.1002/1097-4636(20010915)56:4<536::AID-JBM1125>3.3.CO